BR0101486A - Composições farmacêuticas de uso tópico, aplicadas no tratamento de lesões de pele e/ou mucosas; uso das composições no tratamento de lesões de pele e/ou mucosas e uso de compostos no tratamento de lesões de pele e/ou mucosas - Google Patents

Composições farmacêuticas de uso tópico, aplicadas no tratamento de lesões de pele e/ou mucosas; uso das composições no tratamento de lesões de pele e/ou mucosas e uso de compostos no tratamento de lesões de pele e/ou mucosas

Info

Publication number
BR0101486A
BR0101486A BR0101486-2A BR0101486A BR0101486A BR 0101486 A BR0101486 A BR 0101486A BR 0101486 A BR0101486 A BR 0101486A BR 0101486 A BR0101486 A BR 0101486A
Authority
BR
Brazil
Prior art keywords
treatment
skin
mucosal lesions
pharmaceutical compositions
compounds
Prior art date
Application number
BR0101486-2A
Other languages
English (en)
Other versions
BRPI0101486B8 (pt
BRPI0101486B1 (pt
Inventor
Elisa Mannochio De Souza Russo
Valter Freire Torres Russo
Original Assignee
Cristalia Prod Quimicos Farm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cristalia Prod Quimicos Farm filed Critical Cristalia Prod Quimicos Farm
Priority to BRPI0101486-2A priority Critical patent/BRPI0101486B1/pt
Priority to EP02702183.1A priority patent/EP1404281B1/en
Priority to PCT/BR2002/000037 priority patent/WO2002083086A1/en
Priority to US10/471,623 priority patent/US7737130B2/en
Publication of BR0101486A publication Critical patent/BR0101486A/pt
Priority to HK04107720.8A priority patent/HK1067298A1/zh
Publication of BRPI0101486B1 publication Critical patent/BRPI0101486B1/pt
Publication of BRPI0101486B8 publication Critical patent/BRPI0101486B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"COMPOSIçõES FARMACêUTICAS DE USO TóPICO, APLICADAS NO TRATAMENTO DE LESõES DE PELE E/OU MUCOSAS; USO DAS COMPOSIçõES NO TRATAMENTO DE LESõES DE PELE E/OU MUCOSAS E USO DE COMPOSTOS NO TRATAMENTO DE LESõES DE PELE E/OU MUCOSAS". A presente invenção descreve novas composições farmacêuticas no tratamento de lesões de pele e/ou mucosas, novo uso terapêutico de compostos e uso das composições e compostos no tratamento de lesões que envolvam a pele e/ou mucosas, e/ou em terapias onde a regeneração ou o modelamento do crescimento de tecidos seja necessário. Particularmente estas composições farmacêuticas são indicadas para o tratamento de lesões ocasionadas por queimaduras.
BRPI0101486-2A 2001-04-17 2001-04-17 Pharmaceutical composition for topic use containing heparin for the treatment of skin or mucosal injuries caused by burns BRPI0101486B1 (pt)

Priority Applications (5)

Application Number Priority Date Filing Date Title
BRPI0101486-2A BRPI0101486B1 (pt) 2001-04-17 2001-04-17 Pharmaceutical composition for topic use containing heparin for the treatment of skin or mucosal injuries caused by burns
EP02702183.1A EP1404281B1 (en) 2001-04-17 2002-03-12 Pharmaceutical compositions of topic use, applied in treatment of skin and/or mucous injuries; use of compositions in treatment of skin and/or mucous injuries and use of compounds in treatment of skin and/or mucous injuries
PCT/BR2002/000037 WO2002083086A1 (en) 2001-04-17 2002-03-12 Pharmaceutical compositions of topic use, applied in treatment of skin and/or mucous injuries; use of compositions in treatment of skin and/or mucous injuries and use of compounds in treatment of skin and/or mucous injuries
US10/471,623 US7737130B2 (en) 2001-04-17 2002-03-12 Pharmaceutical compositions for topical use in treatment of skin or mucous injuries
HK04107720.8A HK1067298A1 (zh) 2001-04-17 2004-10-07 應用於治療皮膚和/或粘膜損傷的體表應用的藥物組合物；組合物在治療皮膚和/或粘膜損傷中的用途和化合物在治療皮膚和/或粘膜損傷中的用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0101486-2A BRPI0101486B1 (pt) 2001-04-17 2001-04-17 Pharmaceutical composition for topic use containing heparin for the treatment of skin or mucosal injuries caused by burns

Publications (3)

Publication Number Publication Date
BR0101486A true BR0101486A (pt) 2004-07-06
BRPI0101486B1 BRPI0101486B1 (pt) 2017-09-19
BRPI0101486B8 BRPI0101486B8 (pt) 2021-05-25

Family

ID=3947104

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0101486-2A BRPI0101486B1 (pt) 2001-04-17 2001-04-17 Pharmaceutical composition for topic use containing heparin for the treatment of skin or mucosal injuries caused by burns

Country Status (5)

Country Link
US (1) US7737130B2 (pt)
EP (1) EP1404281B1 (pt)
BR (1) BRPI0101486B1 (pt)
HK (1) HK1067298A1 (pt)
WO (1) WO2002083086A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE432072T1 (de) 2002-03-12 2009-06-15 Galderma Res & Dev Verwendung von adapalen zur behandlung dermatologischer erkrankungen
CN1269846C (zh) 2005-04-20 2006-08-16 凌沛学 肝素银的制备及其应用
US8592393B2 (en) 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
EP2205642B1 (en) 2007-11-02 2016-01-27 Momenta Pharmaceuticals, Inc. Non-anticoagulant polysaccharide compositions
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US20110200683A1 (en) * 2010-02-16 2011-08-18 Piper Medical, Inc Hydrogen peroxide solution producing first aid substance, packaging, and treatment
CN102985443B (zh) 2010-04-16 2017-05-10 动量制药公司 组织靶向
IT1400232B1 (it) * 2010-05-07 2013-05-24 Advance Holdings Ltd Composizione farmaceutica topica comprendente eparina
BR112012031906A2 (pt) * 2010-06-17 2016-08-23 Momenta Pharmaceuticals Inc métodos e composições para modular o crescimento de cabelo e pelos.
CN104013570B (zh) * 2013-03-02 2017-12-05 山东新时代药业有限公司 一种依诺肝素钠注射液及其制备工艺
BR112015027158A8 (pt) * 2013-05-02 2018-08-14 Next Science Llc Composição antimicrobiana de alta osmolaridade contendo um ou mais solventes orgânicos
WO2014193818A1 (en) 2013-05-28 2014-12-04 Momenta Pharmaceuticals, Inc. Pharmaceutical compositions
EP3104839B1 (en) 2014-02-10 2019-11-13 Troikaa Pharmaceuticals Ltd Topical formulations of heparin
CN105832663A (zh) * 2016-06-03 2016-08-10 邱阳 预防骨科或外科手术后静脉血栓的注射液及其制备方法
CN109091456A (zh) * 2018-10-22 2018-12-28 成都市海通药业有限公司 一种肝素钠注射液及其制备方法
CN114272384A (zh) * 2021-12-24 2022-04-05 厦门一泰消防科技开发有限公司 消防用水添加剂在烧烫伤应急处置中的用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837019A (en) * 1986-08-11 1989-06-06 Charles Of The Ritz Group Ltd. Skin treatment composition and method for treating burned skin
US5037810A (en) * 1987-03-17 1991-08-06 Saliba Jr Michael J Medical application for heparin and related molecules
DK505488D0 (da) * 1987-12-21 1988-09-09 Bar Shalom Daniel Middel og anvendelse af samme
IE891173L (en) * 1988-04-18 1989-10-18 Univ Utrecht Composition for promoting hair growth in androgenetic¹alopecia and method thereof
IL95952A0 (en) * 1989-10-19 1991-07-18 Sterling Drug Inc Aerosol composition for topical medicament
JP2613128B2 (ja) * 1990-10-01 1997-05-21 三菱電機株式会社 半導体装置
IT1245761B (it) * 1991-01-30 1994-10-14 Alfa Wassermann Spa Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
US6492349B1 (en) * 1993-03-31 2002-12-10 Nutramax Laboratories, Inc. Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
US6730323B1 (en) * 1996-12-18 2004-05-04 Care Teck Laboratories, Inc. Microclysmic gel for treatment of tissue trauma and burns
US6255295B1 (en) * 1996-12-23 2001-07-03 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue
AU7484198A (en) * 1997-05-12 1998-12-08 Sage Pharmaceuticals, Inc. Topical spray for burn treatment and anti-infection
JP3641152B2 (ja) * 1999-02-17 2005-04-20 株式会社ヤクルト本社 皮膚外用剤
JP2000302664A (ja) * 1999-04-22 2000-10-31 Pola Chem Ind Inc ぬめり感のない皮膚外用剤

Also Published As

Publication number Publication date
BRPI0101486B8 (pt) 2021-05-25
HK1067298A1 (zh) 2005-04-08
EP1404281A1 (en) 2004-04-07
EP1404281B1 (en) 2016-03-09
US7737130B2 (en) 2010-06-15
EP1404281A4 (en) 2010-01-20
US20040087544A1 (en) 2004-05-06
WO2002083086A1 (en) 2002-10-24
BRPI0101486B1 (pt) 2017-09-19

Similar Documents

Publication Publication Date Title
BR0101486A (pt) Composições farmacêuticas de uso tópico, aplicadas no tratamento de lesões de pele e/ou mucosas; uso das composições no tratamento de lesões de pele e/ou mucosas e uso de compostos no tratamento de lesões de pele e/ou mucosas
BRPI0418029A (pt) formulação de anticorpos cd40 e métodos
DE60138549D1 (de) Topische gel-abgabesysteme zur behandlung von hauterkrankungen
BR9507506A (pt) Processo para exterminar uma célula processo para tratamento de càncer composição e kit terapéutico
BRPI0417666A (pt) composição para tratamento oral ou pessoal, método para administrar um material funcional a um sujeito humano ou animal, e, processo para preparar uma composição para tratamento oral ou pessoal
BR0317747A (pt) Método de tratamento terapêutico concomitante de um indivìduo, composição farmacêutica, kit, uso de um primeiro agente e um segundo agente, e, métodos de prevenir ou tratar uma doença relacionada com amilóide-b, doença de alzheimer e insuficiência cognitiva suave
BR0205722A (pt) Formulação de liberação prolongada e método para o tratamento de um paciente que sofre de dor
CY2014020I2 (el) Η χρηση του ραδιου -223 για τη στοχευση ασβεστωμενων ιστων για την ανακουφιση πονου και τη θεραπεια οστικου καρκινου
BR0014996A (pt) Método para prevenir ou melhorar a dor de um ferimento fechado cirurgicamente em um indivìduo, e, emplastro
BR0005786B1 (pt) composiÇço de cosmÉtico para o tratamento de cabelo ou pele.
CY1105818T1 (el) Χρησεις του et743 στην θepαπευτικη αγωγη του καρκινου
CY1108633T1 (el) Κοσμητικη συνθεση βασεως σουκραλφατ και θειικων αλατων χαλκου και ψευδαργυρου
ATE516037T1 (de) Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen
BR0215404A (pt) processo e dispositivo para reduzir dosagem terapêutica
BR0200921A (pt) Uso de produtos de legume para o tratamento de agressões externas
ES2113222T3 (es) Utilizacion de derivados de acido benzoico para estimular el proceso de renovacion epidermica y tratar la piel.
MX9708803A (es) Compuestos biaromaticos de propinilo o dienilo.
BR0110971A (pt) Composições e métodos para tratamento de infecções das mucosas
HUP0000873A2 (hu) A levobupivakain arcsebészeti alkalmazása
MXPA03011622A (es) Uso de glicoproteina para el tratamiento y re-epitelizacion de heridas.
BR9807157A (pt) Composto, composição, utilização de um composto e processo de tratamento cosmético dos sinais do envelhecimento cutâneo
NO20071238L (no) Fremgangsmater for leging av skader ved human IL-18 administrering
BR0213410A (pt) Usos farmacêuticos de bisfosfonatos
ATE345805T1 (de) Calciumtrifluoracetat mit zytotoxischer wirkung
BR0311180A (pt) Métodos para o tratamento de doenças e condições respiratórias utilizando um inibidor seletivo da inos

Legal Events

Date Code Title Description
GLA Others concerning applications: notification of judicial decision
FBOS Technical and formal requirements: other requirements
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]

Free format text: DE ACORDO COM O ART.34 "II" DA LPI (LEI 9279, DE 14/05/96), O EXAME FICA SUSPENSO PARA QUE O REQUERENTE APRESENTE DOCUMENTOS NECESSARIOS A REGULARIZACAO DO PROCESSO E EXAME DO PEDIDO.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) DA LPI INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S)

B12B Appeal against refusal [chapter 12.2 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 9/12 (2006.01), A61K 8/73 (2006.01), A61K 9/0

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/04/2001 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 17/04/2021